Healthcare Firms Adopt Authentic Patient Storytelling

Marketing managers can adopt these long-form documentary strategies to humanize clinical branding.

Updated on Oct. 29, 2026 in Healthcare

Isometric editorial illustration of a professional camera on a tripod in a sunlit, minimalist room, symbolizing clinical documentary storytelling.
Healthcare marketing professionals are increasingly adopting long-form documentary storytelling to bridge the gap between clinical branding and authentic patient advocacy. AI Illustration. Upload story photo >

New York-based director Karen Haberberg, known for documenting children with rare genetic conditions, was recently profiled by AtEdge. Her work involves commercial campaigns for major healthcare and pharmaceutical firms while balancing roles as an educator and board member.

Why it matters

Operators in healthcare marketing and communications can look to Haberberg's approach as a model for authentic visual storytelling in high-stakes fields. Her focus on daily, home-based environments creates a distinct, human-centered bridge between clinical messaging and patient advocacy.

The development of Haberberg's documentary project on rare conditions spanned a two-year period. This extended timeline stands in contrast to the typical turnaround for corporate commercial assets in the pharmaceutical sector.

The players

Karen Haberberg

A New York-based healthcare photographer and director who balances commercial pharmaceutical campaigns with patient-focused documentary work.

Pfizer

A global research-based biopharmaceutical company that develops and markets healthcare products and vaccines.

Sarepta Therapeutics

A precision genetic medicine company focused on the development of therapeutics for rare diseases.

The details

Haberberg manages a dual-track career that combines commercial work for large-scale clients like Pfizer, Vabysmo, and Amvuttra with long-form documentary projects. By documenting children with rare diseases in their everyday home environments, she provides a narrative framework that pharmaceutical firms utilize to humanize patient outcomes. Beyond this, she maintains an operational presence in the industry through board service at the APA and the Children's Neuroblastoma Cancer Foundation.

Timeline

  1. Spring 2026: Haberberg presented at the Sarepta Women in RARE Workshop.

  2. October 29, 2026: AtEdge released the profile featuring Haberberg.

Market Landscape

Haberberg's work sits at the intersection of commercial medical advertising and authentic patient-centered storytelling. It follows a trend of pharmaceutical firms seeking deeper, long-form human interest documentation to bolster clinical product messaging.

Operators in the healthcare space should evaluate whether their visual assets effectively reflect patient realities or remain purely clinical. Diversifying content strategies to include deep-dive documentary-style storytelling can help firms build greater trust with patient communities.

The takeaway

Effective medical storytelling requires a balance between rigorous clinical accuracy and the human experience of rare condition management. Managers should track how their current visual campaigns integrate patient-led narratives to improve long-term engagement.

Further reading

For more on evolving standards in clinical communications, see Healthcare.

Source note: This article includes information reported by Adweek.